secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2023-09-20T23:59:59+00:00
Accession:  0001213900-23-077995
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TradeUP Acquisition Corp. enters $10M PIPE agreements with price adjustment for Estrella merger
--------------------------------------------------------------------------------

- Two investors commit $5M each at $10/share; additional shares if VWAP < $8.30 at closing or after 24 months.
- Pro forma combined equity ~$10.9M as of June 30; estimated to drop to ~$6.2M by Oct 2023 due to burn rate.
- Closing conditioned on Business Combination; funds returned if merger doesn't close within 2 business days of expected date.
- Company to file resale registration statement; must be effective within 90 days or 10 business days after SEC notice.
- Subscription agreements include representations, warranties, and indemnification for Securities Act liabilities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000121390023077995/0001213900-23-077995-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000121390023077995/ea185402-8k425_tradeup.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-077995

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer